Earnings History Data for Agios Pharmaceuticals, Inc. (AGIO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-02-2024	PM		AGIO	Agios Pharmaceuticals, Inc.	1,410	-1.72	-1.64	0.67	Agios Pharmaceuticals GAAP EPS of -$6.33 misses by $0.07, revenue of $26.82M misses by $0.9M [2/15/2024 7:01 AM]	26.79	0.89 (3.44%)	25.90	0.0 (0.00%)	19.80 - 29.23	896,833	700,000	467
Agios Pharmaceuticals Q4 2023 Earnings Preview [2/14/2024 2:05 PM] Agios Pharmaceuticals GAAP EPS of -$6.33 misses by $0.07, revenue of $26.82M misses by $0.9M [2/15/2024 7:01 AM]
02-11-2023	PM		AGIO	Agios Pharmaceuticals, Inc.	1,170	-1.64	-1.69	-1.49	Agios Pharmaceuticals GAAP EPS of -$1.64 beats by $0.06, revenue of $7.4M misses by $0.13M [11/2/2023 7:20 AM]	21.00	-0.30 (-1.41%)	21.00	0.0 (0.00%)	19.80 - 31.87	640,103	770,000	8,701
Agios Pharmaceuticals Q3 2023 Earnings Preview [11/1/2023 12:43 PM] Agios Pharmaceuticals GAAP EPS of -$1.64 beats by $0.06, revenue of $7.4M misses by $0.13M [11/2/2023 7:20 AM]
03-08-2023	PM		AGIO	Agios Pharmaceuticals, Inc.	1,490	-1.51	-1.60	-1.68	Agios Pharmaceuticals GAAP EPS of -$1.51 beats by $0.05, revenue of $6.7M beats by $0.24M [8/3/2023 7:19 AM]	25.93	-0.05 (-0.19%)	26.28	0.30 (1.15%)	21.07 - 34.76	321,178	360,000	272
Agios Pharmaceuticals Q2 Earnings Preview [8/2/2023 11:57 AM] Agios Pharmaceuticals GAAP EPS of -$1.51 beats by $0.05, revenue of $6.7M beats by $0.24M [8/3/2023 7:19 AM]
04-05-2023	PM	7:00 AM ET (May 4)	AGIO	Agios Pharmaceuticals, Inc.	1,250	-1.47	-1.72	-1.74	Agios Pharmaceuticals GAAP EPS of -$1.47 beats by $0.23, revenue of $5.6M beats by $0.37M [5/4/2023 7:07 AM]	24.65	1.78 (7.78%)	22.42	-0.45 (-1.97%)	16.75 - 34.76	411,661	500,000	201
Agios Pharmaceuticals Q1 2023 Earnings Preview [5/3/2023 1:42 PM] Agios Pharmaceuticals GAAP EPS of -$1.47 beats by $0.23, revenue of $5.6M beats by $0.37M [5/4/2023 7:07 AM]
23-02-2023	PM	7:00 AM ET (Feb 23)	AGIO	Agios Pharmaceuticals, Inc.	1,520	0.67	-1.59	-1.81	Agios Pharmaceuticals GAAP EPS of -$4.23 beats by $2.06, revenue of $14.24M beats by $0.35M [2/23/2023 7:12 AM]	25.95	-0.57 (-2.15%)	0.0	0.0 (0.00%)	16.75 - 34.76	762,592	490,000	0
Agios Pharmaceuticals GAAP EPS of -$4.23 beats by $2.06, revenue of $14.24M beats by $0.35M [2/23/2023 7:12 AM]
03-11-2022	PM	7:00 AM ET (Nov 3)	AGIO	Agios Pharmaceuticals, Inc.	1,560	-1.49	-1.75	-1.48	Agios Pharmaceuticals GAAP EPS of -$1.49 beats by $0.27, revenue of $3.52M misses by $1.72M [11/3/2022 7:23 AM]	26.37	-1.45 (-5.21%)	27.82	0.0 (0.00%)	16.75 - 50.98	630,391	530,000	12,198
Agios Pharmaceuticals GAAP EPS of -$1.49 beats by $0.27, revenue of $3.52M misses by $1.72M [11/3/2022 7:23 AM] Agios Reports Business Highlights and Third Quarter 2022 Financial Results [Nov-03-22 07:00AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	AGIO	Agios Pharmaceuticals, Inc.	1,120	-1.68	-1.78	-1.36	Agios Pharmaceuticals GAAP EPS of -$1.68 beats by $0.07 [8/4/2022 7:12 AM]	28.58	3.63 (14.55%)	24.95	0.0 (0.00%)	16.75 - 50.98	948,156	580,000	11,122
Agios Pharmaceuticals GAAP EPS of -$1.68 beats by $0.07 [8/4/2022 7:12 AM] Agios stock rises as Q2 sees new drug Pyrukynd bring in revenue [8/4/2022 11:46 AM] Agios Reports Business Highlights and Second Quarter 2022 Financial Results [Aug-04-22 07:00AM]
05-05-2022	PM	7:00 AM ET (May 5)	AGIO	Agios Pharmaceuticals, Inc.	1,290	-1.74	-1.85	-1.31	Agios Pharmaceuticals GAAP EPS of -$1.74 beats by $0.07, revenue of $0.83M misses by $1.88M [5/5/2022 7:16 AM]	22.93	-1.21 (-5.01%)	24.14	0.0 (0.00%)	21.72 - 62.16	661,168	670,000	14,088
Agios Pharmaceuticals Q1 2022 Earnings Preview [5/4/2022 2:02 PM] Agios Pharmaceuticals GAAP EPS of -$1.74 beats by $0.07, revenue of $0.83M misses by $1.88M [5/5/2022 7:16 AM] Agios Reports Business Highlights and First Quarter 2022 Financial Results [May-05-22 07:00AM] Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Lags Revenue Estimates [May-05-22 08:15AM]
24-02-2022	PM	7:10 AM ET (Feb 24)	AGIO	Agios Pharmaceuticals, Inc.	1,570	-1.81	-1.69	-1.41	Agios Pharmaceuticals GAAP EPS of -$1.81 misses by $0.12 [2/24/2022 7:12 AM]	29.42	-0.04 (0.00%)	0.0	0.0 (0.00%)	28.02 - 62.16	1,018,523	662,431	0
Agios Pharmaceuticals Q4 2021 Earnings Preview [2/23/2022 2:16 PM] Agios Pharmaceuticals GAAP EPS of -$1.81 misses by $0.12 [2/24/2022 7:12 AM] Biotech Stock Roundup: SAGE, ATRA Down on Study Updates, AGIO Drug Approval & More [Feb-23-22 12:57PM] Agios Reports Fourth Quarter and Full Year 2021 Financial Results [Feb-24-22 07:00AM] Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Lags Revenue Estimates [Feb-24-22 08:55AM] The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Sage Therapeutics, Biogen Agios Pharmaceuticals Atara Biotherapeutics [Feb-24-22 12:03PM] Agios (AGIO) Loss Wider Than Expected in Q4, Revenues Nil [Feb-24-22 05:49PM]
03-11-2021	PM	7:00 AM ET (Nov 3)	AGIO	Agios Pharmaceuticals, Inc.	2,930	-1.48	-1.61	-1.43	Agios Pharmaceuticals EPS beats by $1.46 [11/3/2021 7:13 AM]	49.58	-0.20 (-0.40%)	49.78	0.0 (0.00%)	32.47 - 62.16	695,354	300,000	27,357
Agios Pharmaceuticals Q3 2021 Earnings Preview [11/2/2021 10:23 AM] Agios Pharmaceuticals EPS beats by $1.46 [11/3/2021 7:13 AM] Agios Reports Business Highlights and Third Quarter 2021 Financial Results [Nov-03-21 07:11AM] Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Misses Revenue Estimates [Nov-03-21 08:35AM] Agios (AGIO) Reports Narrower-Than-Expected Loss in Q3 [Nov-03-21 01:27PM] Agios Pharmaceuticals, inc (AGIO) Q3 2021 Earnings Call Transcript [Nov-03-21 02:30PM]
29-07-2021	PM	7:00 AM ET (Jul 29)	AGIO	Agios Pharmaceuticals, Inc.	2,990	-1.36	-1.39	-1.31	Agios Pharmaceuticals EPS misses by $0.12 [7/29/2021 7:09 AM]	49.81	-0.18 (-0.37%)	50.00	0.0 (0.00%)	32.47 - 62.16	700,109	1,000,000	13,044
Agios Pharmaceuticals Q2 2021 Earnings Preview [7/28/2021 11:00 AM] Agios Pharmaceuticals EPS misses by $0.12 [7/29/2021 7:09 AM] Agios Reports Business Highlights and Second Quarter 2021 Financial Results [Jul-29-21 07:00AM] Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Misses Revenue Estimates [Jul-29-21 08:25AM] Agios Pharmaceuticals, inc (AGIO) Q2 2021 Earnings Call Transcript [Jul-29-21 05:00PM]
29-04-2021	PM	7:00 AM ET (Apr 29)	AGIO	Agios Pharmaceuticals, Inc.	3,920	-1.31	-1.23	-0.59	Agios Pharmaceuticals EPS misses by $0.04 [4/29/2021 7:05 AM]	55.78	0.36 (0.65%)	55.42	0.0 (0.00%)	32.47 - 58.93	661,490	620,000	2,330
Agios Pharmaceuticals Q1 2021 Earnings Preview [4/28/2021 12:16 PM] Agios Pharmaceuticals EPS misses by $0.04 [4/29/2021 7:05 AM] Agios posts wider Q1 loss as R&D expenses rise [4/29/2021 8:04 AM] Agios Pharmaceuticals, Inc. to Host Earnings Call [Apr-29-21 05:45AM] Agios Reports Business Highlights and First Quarter 2021 Financial Results [Apr-29-21 07:00AM] Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Lags Revenue Estimates [Apr-29-21 09:25AM] Agios Pharmaceuticals Inc (AGIO) Q1 2021 Earnings Call Transcript [Apr-29-21 06:30PM]
25-02-2021	PM	7:00 AM ET (Feb 25)	AGIO	Agios Pharmaceuticals, Inc.	3,760	-1.41	-1.41	-1.60	Agios Pharmaceuticals EPS misses by $0.10, beats on revenue [2/25/2021 7:13 AM]	50.36	-2.53 (-4.78%)	56.00	3.11 (5.88%)	27.77 - 58.93	527,753	751,434	114
Agios Pharmaceuticals EPS misses by $0.10, beats on revenue [2/25/2021 7:13 AM] Agios Pharmaceuticals Q4 2020 Earnings Preview [2/24/2021 11:55 AM] Agios Reports Fourth Quarter and Full Year 2020 Financial Results [Feb-25-21 07:00AM] Agios Pharmaceuticals, Inc. to Host Earnings Call [Feb-25-21 06:15AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	AGIO	Agios Pharmaceuticals, Inc.	2,860	-1.43	-1.40	-1.81	Agios Pharmaceuticals EPS misses by $0.06, misses on revenue [11/5/2020 7:10 AM]	42.10	0.58 (1.41%)	42.08	-0.02 (-0.06%)	27.77 - 56.74	593,999	788,362	8,433

30-07-2020	PM	7:00 AM ET (Jul 30)	AGIO	Agios Pharmaceuticals, Inc.	3,530	-1.31	-1.42	-1.87	Agios Pharmaceuticals EPS beats by $0.08, beats on revenue [7/30/2020 7:01 AM]	47.76	-1.64 (-3.32%)	49.40	0.0 (0.00%)	27.77 - 56.74	312,291	429,016	9,166